10-Acetyl docetaxel
CAS: 125354-16-7
Ref. 3D-FA46386
| 2mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
- (2alpha,5beta,7beta,10beta,13alpha)-4,10-Diacetoxy-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
- benzenepropanoic acid, beta-[[(1,1-dimethylethoxy)carbonyl]amino]-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (alphaR,betaS)-
- (2alpha,5beta,7beta,10beta,13alpha)-4,10-bis(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
Docetaxel is a chemotherapy drug that belongs to the class of taxanes. It has been shown to induce apoptotic cell death in prostate cancer cells, which may be due to the induction of messenger RNA, growth factor, and transcription-polymerase chain reaction. Docetaxel also has a multidrug resistance mechanism and is effective against a wide range of cancer types. Docetaxel can be used in conjunction with other chemotherapeutic agents such as cisplatin or 5-fluorouracil for the treatment of solid tumors. In addition, docetaxel can be used as an adjuvant treatment for breast cancer after surgery or radiation therapy. Docetaxel is also effective against some forms of leukemia and lymphoma.
Propiedades químicas
Consulta técnica sobre: 3D-FA46386 10-Acetyl docetaxel
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
